A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results

Sharma, P.; Wani, S.; Weston, A. P.; Bonsai, A.; Hall, M.; Mathur, S.; Prasad, A.; Sampliner, R. E.
September 2006
Gut;Sep2006, Vol. 55 Issue 9, p1233
Academic Journal
Background: Many modalities have been used to ablate Barrett's oesophagus (BO). However, long term results and comparative effectiveness are unknown. Aims: Our aim was to compare the long term efficacy of achieving complete reversal (endoscopic and histological) between multipolar electrocoagulation (MPEC) and argon plasma coagulation (APC) in BO patients and assess factors influencing successful ablation. Methods: Patients with BO, 2-6 cm long, underwent 24 hour pH testing on proton pump inhibitor (PPI) therapy. Patients were then randomised by BO length to undergo ablation with MPEC or APC every 4- 8 weeks until endoscopic reversal or maximal of six treatment sessions. Results: Thirty five BO patients have been followed for at least two years following endoscopic ablation, 16 treated with MPEC and 19 with APC. There was complete reversal of BO in 24 patients (69%); 75% with MPEC and 63% with APC (p = 0.49). There was no difference in the number of sessions required in the two groups. There was no difference in age, pH results, BO length, PPI dose, or hiatal hernia size between patients with and without complete reversal. One patient developed an oesophageal stricture but there were no major complications such as bleeding or perforation. Conclusions: In BO patients treated with MPEC or APC in combination with acid suppression, at long term follow up, complete reversal of BO can be maintained in approximately 70% of patients, irrespective of the technique. There are no predictors associated with achieving complete reversal of BO. Continued surveillance is still indicated in the post ablative setting. As yet, these techniques are not ready for clinical application (other than for high grade dysplasia or early oesophageal adenocarcinoma) and cannot be offered outside the research arena.


Related Articles

  • Reflux und Hiatushernie im Spannungsfeld zwischen konservativer und operativer Therapie. Freys, S.M.; Heimbucher, J. // Der Chirurg;Dec2014, Vol. 85 Issue 12, p1046 

    Approximately 20 % of the population are affected by gastroesophageal reflux disease (GERD). The subjective clinical and objective pathological extent of the disease is highly variable and the underlying pathophysiological mechanisms extraordinarily diverse. The importance of hiatus hernia for...

  • Combined Endoscopic Thermal Electrocoagulation with High Dose Omeprazole Therapy in Complicated Heterotopic Gastric Mucosa of the Esophagus. McBride, Matthew A.; Vanagunas, Arvydas A.; Breshnahan, Joseph P.; Barch, David B. // American Journal of Gastroenterology;Nov1995, Vol. 90 Issue 11, p2029 

    We report a case of a 38-yr-old man presenting with dysphagia due to stricturing of an isolated patch of heterotopic acid-secreting gastric mucosa ("inlet patch") in the proximal esophagus who was successfully treated with endoscopic thermal coagulation while receiving acid suppression with a...

  • Intragastric manometric measurements of patients with hiatal hernia: A prospective controlled study. Peker, Kemal; İnal, Abdullah; Emiroğlu, Mustafa; Yılmaz, İsmayil; Demiryılmaz, İsmail; Işık, Arda // Journal of Clinical & Experimental Investigations / Klinik ve De;Mar2014, Vol. 5 Issue 1, p1 

    Objective: Hiatal hernia is a disorder in which abdominal contents, especially gastroesophageal junction and proximal stomach are displaced through an incompetent esophageal hiatus into mediastinum. Aim of this study is to investigate the relationship betweeen intragastric pressure and...

  • Miscellaneous.  // Current Medical Literature: Gastroenterology;2010, Vol. 29 Issue 1, p28 

    The article discusses studies related to gastroenterology. Two randomized trials were analyzed concerning the clinical efficacy and pharmacodynamic effect of clopidogrel and prasugrel with the use of a proton-pump inhibitor and without. Another study examined the epidemiology of eosinophilic...

  • Editorial: Should Patients With Suspected Eosinophilic Esophagitis Undergo a Therapeutic Trial of Proton Pump Inhibition? Hirano, Ikuo // American Journal of Gastroenterology;Mar2013, Vol. 108 Issue 3, p373 

    Interaction with gastroesophageal reflux disease (GERD) has been a fundamental consideration in eosinophilic esophagitis (EoE) since the initial reports of this emerging entity. While studies from the '80s identified the presence of esophageal eosinophilia as being a histologic marker for the...

  • Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy. Shaheen, Nicholas J; Denison, Hans; Björck, Karin; Silberg, Debra G // American Journal of Gastroenterology;Apr2013, Vol. 108 Issue 4, p529 

    OBJECTIVES:Approximately 20-30% of patients with gastroesophageal reflux disease (GERD) do not experience complete symptom resolution during proton pump inhibitor (PPI) therapy. The aim of this study was to determine the prevalence of esophageal mucosal breaks among patients who have a partial...

  • Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Ours, Tina M.; Fackler, W.Keith; Richter, Joel E.; Vaezi, Michael F. // American Journal of Gastroenterology;Mar2003, Vol. 98 Issue 3, p545 

    : ObjectivesPrevious studies suggest that the addition of H2 receptor antagonist (H2RA) therapy is more effective than proton pump inhibitor (PPI) therapy alone in reducing nocturnal acid breakthrough (NAB). However, the clinical significance of NAB with respect to esophageal acid control has...

  • All PPIs equivalent for treatment of GERD.  // Journal of Family Practice;Dec2005, Vol. 54 Issue 12, p1024 

    This article cites a research study, which examines the differences between proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD). This study is in form of a meta-analysis, which identified all double-blinded randomized controlled trials comparing one PPI with...

  • Recognising hiatus hernia.  // British Medical Journal;6/19/1976, Vol. 1 Issue 6024, p1490 

    Examines the symptoms and signs in identification hiatus hernia. Implications of size changes; Identification of the oesophageal and gastric epithelia junction; Assessment of the position of the stomach and oesophagus junction.


Read the Article


Sign out of this library

Other Topics